ATE37365T1 - (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. - Google Patents

(3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Info

Publication number
ATE37365T1
ATE37365T1 AT84114464T AT84114464T ATE37365T1 AT E37365 T1 ATE37365 T1 AT E37365T1 AT 84114464 T AT84114464 T AT 84114464T AT 84114464 T AT84114464 T AT 84114464T AT E37365 T1 ATE37365 T1 AT E37365T1
Authority
AT
Austria
Prior art keywords
compounds
dihydrobenzofuran
alkylamines
medicines
aryl
Prior art date
Application number
AT84114464T
Other languages
English (en)
Inventor
John J Tegeler
Craig J Eagle Rock Vil Diamond
Grover C Helsley
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of ATE37365T1 publication Critical patent/ATE37365T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/62—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT84114464T 1983-12-07 1984-11-29 (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. ATE37365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/559,134 US4602035A (en) 1983-12-07 1983-12-07 Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
EP84114464A EP0149077B1 (de) 1983-12-07 1984-11-29 (3-Aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE37365T1 true ATE37365T1 (de) 1988-10-15

Family

ID=24232407

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84114464T ATE37365T1 (de) 1983-12-07 1984-11-29 (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Country Status (7)

Country Link
US (1) US4602035A (de)
EP (1) EP0149077B1 (de)
JP (1) JPS60139684A (de)
AT (1) ATE37365T1 (de)
DE (1) DE3474143D1 (de)
DK (1) DK583084A (de)
GR (1) GR81183B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584723B1 (fr) * 1985-07-09 1988-02-12 Adir Nouveaux derives du dihydro-2,3 benzofuranne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4873241A (en) * 1988-10-31 1989-10-10 Fisons Corporation 2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epileptics
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA110324C2 (en) 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
ME02754B (de) 2011-03-23 2018-01-20 Trevena Inc Opioidrezeptorliganden und verfahren zu ihrer verwendung und herstellung
EP3314283A4 (de) * 2015-06-29 2019-02-27 The Research Foundation of the State University of New York Dynamische phantom für funktionelle magnetresonanzbildgebung
US10588889B2 (en) 2015-12-14 2020-03-17 Trevena, Inc. Methods of treating hyperalgesia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3103520A (en) * 1963-09-10 Aminobenzoxacycloalkanes
US2513698A (en) * 1945-03-09 1950-07-04 Abbott Lab 2 (3) benxofuranone derivatives and methods of making them
GB627839A (en) * 1945-03-09 1949-08-17 Abbott Lab Improvements in the production of benzofuranone derivatives
US3156688A (en) * 1962-11-05 1964-11-10 Abbott Lab Nu-alkyl and nu-aralkyl benzoxacycloalkanemethylamines
US3122551A (en) * 1962-11-05 1964-02-25 Abbott Lab N-alkyl and n-aralkyl benzoxacycloalkaneamides
GB1143703A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes

Also Published As

Publication number Publication date
JPS60139684A (ja) 1985-07-24
DE3474143D1 (en) 1988-10-27
DK583084A (da) 1985-06-08
DK583084D0 (da) 1984-12-06
EP0149077B1 (de) 1988-09-21
US4602035A (en) 1986-07-22
GR81183B (en) 1985-04-08
EP0149077A1 (de) 1985-07-24

Similar Documents

Publication Publication Date Title
ATE38661T1 (de) Zwischenprodukt und verfahren zu dessen herstellung.
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
PT78377A (en) Process for preparing microbicides based on n-(2-nitrophenyl)-4-amino-pyrimidine derivatives
DE69025941D1 (de) Dem Physostigmin verwandte 4- und 6-Carbamate, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
PT77924A (de) Disubstituierte prolinderivate verfahren zu ihrer herstellung und ihre verwendung
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE68000T1 (de) Beta-d-phenyl-thioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
DE3883456D1 (de) Verfahren zur Herstellung von substituierten Indolinonderivaten.
ATE37365T1 (de) (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE48835T1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
FI88795B (fi) Foerfarande foer framstaellning av tienyletylaminer
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
HUP0100453A1 (hu) Eljárás izokarbamidok előállítására
ATE106082T1 (de) 4,5,7,8-tetrahydro-6h-thiazolo(5,4-d>azepine, ihre herstellung und ihre verwendung als arzneimittel.
DE3780015D1 (de) Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE111899T1 (de) 1,2,3,4-tetrahydro-1,9-acridindiamine, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE38515T1 (de) Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung.
DE68902386D1 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE28200T1 (de) Spiro(benzofuran-azalkane), eine methode zu deren herstellung und ihre verwendung als medikamente.
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
ATE28858T1 (de) Derivate von n-(methoxyphenacyl)aminen, ihre therapeutische verwendung und verfahren zu ihrer herstellung.
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
ATE43585T1 (de) Neue imidazolylverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE32069T1 (de) Analgetische dibenz(b,f>oxepine, ein verfahren zu ihrer herstellung und ihre verwendung als heilmittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee